Upcoming event on March 7th! Alzheimer’s Disease Public Education Forum
February 24, 2021 — You are invited to the 2021 Alzheimer's Disease Public Educational Forum on Sunday, March 7, 10:30am -12:30pm PT. Held by Mount Sinai Medical Center, Florida ADRC, and Biogen. Leading experts answer the top questions from the public about Alzheimer's disease. Register at the link.
Upcoming Symposium! April 9th, 10am-1pm PT: Cognitive Reserve, Resilience, and Resistance
February 24, 2021 — You are invited to a special Boston University ADRC symposium on April 9th. Renowned experts will be presenting an overview of their work on cognitive reserve, resilience, and resistance. Highlights include research on factors and underlying mechanisms that may determine an individual’s ability to avoid cognitive impairment. These presentations will help to shed more light on how some are able to remain cognitively healthy through aging and to identify effective dementia prevention strategies. Register at the link
The Institute on Methods and Protocols for Advancement in Clinical Trials in ADRD (IMPACT-AD) now accepting applications for its class of 2021.
February 02, 2021 — The Institute on Methods and Protocols for Advancement in Clinical Trials in ADRD (IMPACT-AD) is now accepting applications for its class of 2021. IMPACT-AD is an exciting opportunity for interested researchers to receive comprehensive training in clinical trials for ADRD. The course will be in person and will offer two simultaneous and overlapping tracks. IMPACT-AD is an exciting opportunity for interested researchers to receive comprehensive training in clinical trials for ADRD. Apply by April 30, 2021 for course in September 2021.
Three New Funding Opportunities - NIA Impact Collaboratory
February 02, 2021 — The NIA Impact Collaboratory has announced 3 new funding opportunities that will support research and training aimed at increasing the nation's capacity to conduct pragmatic clinical trials of non-pharmacological interventions with healthcare systems to improve the care of people living with AD/ADRD and their care partners.
Penn Frontotemporal Degeneration (FTD) Center’s virtual conference: Fighting for the Future: Education and Support for Familial FTD/ALS
January 28, 2021 — Our colleagues at the Penn Frontotemporal Degeneration (FTD) Center presents: Fighting for the Future: Education and Support for Familial FTD/ALS, a virtual conference on Saturday, February 27, 2021 from 6AM-9AM PT. This live event will address the unique challenges and situations that arise from familial or genetic disease. This event will give families the chance to hear from genetic counselors, neurologists, and social workers on the genetics of FTD and ALS.
Announcing the Spring 2021 Round of the Royalty Research Fund grant program
January 15, 2021 — The Office of Research invites applications to the Spring 2021 round of the Royalty Research Fund (RRF) grant program. The purpose of the RRF is to advance new directions in research. Proposals are due Monday, March 1, by 5:00 PM. Awards will be announced by June 15, 2021.
New Round of Innovation Grants - The Garvey Institute for Brain Health Solutions
January 13, 2021 — For the current round of funding, the Institute is looking for innovative uses of technology that have potential to improve access to behavioral health care. Letters of Interest are due February 26. Learn more at the link.
A New Year’s Message of Thanks to Our Research Participants
January 08, 2021 — The ADRC Clinical Core study team shares thoughts of gratitude and hope for 2021
Monday, Jan 11 ADRC Seminar: Integration of mouse and human studies for biomarker discovery in VCID (Vascular contributions to cognitive impairment and dementia)
January 07, 2021 — We welcome you to attend the next ADRC Seminar on Monday, January 11 at 12pm - 1pm. Presenter: Donna M. Wilcock, PhD, Assistant Dean of Biomedicine/ Associate Director, Sanders-Brown Center on Aging/ Robert P. and Mildred A. Moores Endowed Chair in Alzheimer’s Disease/ Professor, Department of Physiology, University of Kentucky College of Medicine.
Watch: Overview of the U19 Human AD Center of the Allen Institute for Brain Science, UW, and Kaiser Permanente Research Institute
December 17, 2020 — The Human AD Center: A platform for cell type-level transcriptomic, epigenomic and spatial interrogation of early selective vulnerability in Alzheimer's disease. Speakers: C. Dirk Keene, MD, PhD / Ed Lein, PhD. Host: UW Neurological Surgery Education Series